More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.41B
EPS
0.61
P/E ratio
29.3
Price to sales
0.7
Dividend yield
--
Beta
1.023191
Previous close
$18.39
Today's open
$18.54
Day's range
$17.70 - $18.54
52 week range
$14.75 - $30.02
show more
CEO
L. Reade Fahs
Employees
13411
Headquarters
Alpharetta, GA
Exchange
Nasdaq Global Select
Shares outstanding
79069313
Issue type
Common Stock
Consumer Discretionary
Retail - Discretionary
Here's Why National Vision (EYE) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Aug 17, 2026

National Vision Stock Down Despite Q2 Earnings & Revenue Beat
EYE beats Q2 earnings and revenue estimates, expands operating margin and raises its 2026 profit outlook despite gross margin pressure.
Zacks Investment Research • Aug 13, 2026

National Vision Q2 Earnings Call Highlights
National Vision NASDAQ: EYE reported second-quarter 2026 revenue growth and improved profitability as higher average ticket sales and premium product attachment offset lower customer traffic, including temporary disruption from an e-commerce platform transition.
MarketBeat • Aug 12, 2026

National Vision Holdings, Inc. (EYE) Q2 2026 Earnings Call Transcript
National Vision Holdings, Inc. (EYE) Q2 2026 Earnings Call Transcript
Seeking Alpha • Aug 12, 2026

National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results
ALPHARETTA, Ga.--(BUSINESS WIRE)-- #nationalvision--National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its second quarter 2026 results.
Business Wire • Aug 12, 2026

National Vision (EYE) Surpasses Q2 Earnings and Revenue Estimates
National Vision (EYE) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago.
Zacks Investment Research • Aug 12, 2026

National Vision (EYE) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for National Vision (EYE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research • Aug 12, 2026

National Vision Holdings, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call
ALPHARETTA, Ga.--(BUSINESS WIRE)-- #nationalvision--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its second quarter 2026 financial results before the market opens on Wednesday, August 12, 2026, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the “Investors” section of the Company's website at https://ir.nationalvision.com. A live audio webcast of the confer.
Business Wire • Jul 29, 2026

Allspring Common Stock Fund Q2 2026 Fund Performance And Attribution
The Allspring Common Stock Fund outperformed the Russell 2500 Index during the second quarter, driven primarily by allocation decisions, with security selection also contributing positively. Health care was the largest contributor to relative results, driven by strong stock selection across several holdings. Conversely, consumer discretionary detracted from results, driven primarily by weakness within the specialty retail industry.
Seeking Alpha • Jul 21, 2026

Rise Nano Optics Announces Strategic Partnership with SportifEye Optics to Produce and Commercialize SpectraGuard(TM) Lenses in the United States
Expanding Lab Partnership Network now includes expertise in Sport, Safety and Performance Eyewear Vancouver, British Columbia--(Newsfile Corp. - June 24, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced a strategic partnership with SportifEye Optics ("SportifEye"), a cutting-edge, full-service optical laboratory and VSP®-Authorized Lab based in Southern California, to support the production and commercialization of its SpectraGuard lens technology in the United States.
Newsfile Corp • Jun 24, 2026

¹ Disclosures

Open an M1 investment account to buy and sell National Vision Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.